Theriva Biologics, Inc. (TOVX)

0.1943 -0.01 (-4.24%) USD  |  NYAM  |  Dec 24, 12:59
0.23 +0.04 (+18.37%) After-Hours: 13:59
More

Theriva Biologics SG&A Expense (TTM): 16.21M for Sept. 30, 2025

SG&A Expense (TTM) Chart

View SG&A Expense (TTM) for TOVX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View SG&A Expense (TTM) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

SG&A Expense (TTM) Range, Past 5 Years

View SG&A Expense (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (TTM) Benchmarks

View SG&A Expense (TTM) Benchmarks
Start Trial
NovaBay Pharmaceuticals, Inc. 8.584M
Palatin Technologies, Inc. 7.449M
Oragenics, Inc. 6.832M
NanoViricides, Inc. 3.611M
Actinium Pharmaceuticals, Inc. 15.79M